| 1.6 |
4.9 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 1.4 |
4.1 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.3 |
3.8 |
GO:0030421 |
defecation(GO:0030421) |
| 1.1 |
2.2 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.0 |
3.0 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.9 |
0.9 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.9 |
2.7 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.9 |
0.9 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.8 |
3.4 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.8 |
2.5 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.8 |
4.0 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.8 |
3.2 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.8 |
0.8 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 |
2.2 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.7 |
0.7 |
GO:0032817 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
| 0.7 |
2.2 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.7 |
2.2 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.7 |
2.8 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.7 |
2.0 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.7 |
2.7 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.7 |
2.0 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.7 |
5.3 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.7 |
2.6 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.7 |
1.3 |
GO:0072239 |
metanephric glomerulus vasculature development(GO:0072239) |
| 0.6 |
3.2 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.6 |
1.9 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.6 |
1.9 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.6 |
2.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.6 |
0.6 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.6 |
2.4 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.6 |
3.0 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.6 |
0.6 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.6 |
0.6 |
GO:0035933 |
glucocorticoid secretion(GO:0035933) corticosterone secretion(GO:0035934) |
| 0.6 |
0.6 |
GO:0045823 |
positive regulation of heart contraction(GO:0045823) |
| 0.6 |
2.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.6 |
2.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.6 |
1.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.6 |
2.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.6 |
1.1 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.6 |
0.6 |
GO:1901630 |
negative regulation of presynaptic membrane organization(GO:1901630) |
| 0.6 |
1.7 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.6 |
2.8 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 0.6 |
1.7 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.5 |
3.2 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.5 |
0.5 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.5 |
1.6 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.5 |
2.6 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.5 |
1.5 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 0.5 |
1.5 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.5 |
0.5 |
GO:2000380 |
regulation of mesoderm development(GO:2000380) |
| 0.5 |
2.5 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.5 |
1.4 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.5 |
1.0 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.5 |
1.4 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.5 |
2.4 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.4 |
1.8 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.4 |
2.2 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.4 |
1.3 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.4 |
2.2 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.4 |
1.8 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.4 |
1.3 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.4 |
1.3 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.4 |
1.8 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 |
0.4 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) interleukin-4-mediated signaling pathway(GO:0035771) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
| 0.4 |
2.6 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.4 |
1.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 |
2.6 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.4 |
0.9 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.4 |
1.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.4 |
2.9 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.4 |
2.1 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.4 |
3.8 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.4 |
1.6 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.4 |
5.3 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.4 |
1.2 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.4 |
1.2 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.4 |
1.2 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.4 |
1.2 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.4 |
1.2 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.4 |
1.6 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.4 |
0.4 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.4 |
0.4 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.4 |
0.8 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.4 |
1.5 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 0.4 |
3.0 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.4 |
1.1 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
1.1 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.4 |
1.1 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.4 |
4.0 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.4 |
0.4 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.4 |
1.8 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.4 |
1.1 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.4 |
2.8 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.4 |
0.7 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.4 |
1.1 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.3 |
1.0 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.3 |
0.7 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.3 |
3.5 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.3 |
3.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 |
2.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.3 |
0.3 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.3 |
0.3 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.3 |
1.0 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.3 |
1.4 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.3 |
1.3 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.3 |
1.0 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 |
1.0 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.3 |
3.0 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.3 |
0.3 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.3 |
1.3 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.3 |
1.3 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.3 |
2.8 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.3 |
3.4 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.3 |
0.9 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.3 |
1.5 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.3 |
0.9 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 |
1.2 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.3 |
0.9 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.3 |
0.9 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
0.3 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 |
0.9 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.3 |
0.6 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.3 |
1.2 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 |
0.9 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
0.6 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 0.3 |
1.2 |
GO:2000851 |
positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.3 |
0.3 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.3 |
0.9 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.3 |
0.9 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.3 |
0.6 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.3 |
0.9 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.3 |
1.2 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.3 |
1.8 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.3 |
1.2 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.3 |
3.2 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.3 |
2.6 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.3 |
0.6 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.3 |
1.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
1.7 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.3 |
1.4 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) |
| 0.3 |
0.6 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.3 |
2.5 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.3 |
2.5 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.3 |
1.4 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.3 |
1.1 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.3 |
0.3 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.3 |
1.4 |
GO:0061141 |
lung ciliated cell differentiation(GO:0061141) |
| 0.3 |
0.3 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 |
2.2 |
GO:1901534 |
positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.3 |
1.1 |
GO:1904426 |
positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.3 |
0.8 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.3 |
0.8 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.3 |
0.3 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.3 |
1.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.3 |
0.8 |
GO:1900426 |
positive regulation of defense response to bacterium(GO:1900426) |
| 0.3 |
1.8 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.3 |
1.6 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.3 |
0.8 |
GO:0031990 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.3 |
0.5 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.3 |
1.6 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 |
0.8 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.3 |
0.8 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 0.3 |
1.0 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.3 |
0.8 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.3 |
0.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
0.8 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.3 |
1.0 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
5.7 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
0.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.5 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 |
1.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.7 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.2 |
0.5 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.2 |
1.5 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.2 |
1.9 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 |
0.2 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) |
| 0.2 |
1.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
1.0 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.2 |
0.2 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) |
| 0.2 |
0.7 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.2 |
1.7 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
0.5 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.2 |
0.7 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.2 |
0.2 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.2 |
0.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
0.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.2 |
1.9 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.2 |
0.2 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.2 |
0.7 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.2 |
0.9 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.2 |
1.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
1.1 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.2 |
1.8 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.2 |
0.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.2 |
0.7 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.2 |
1.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
1.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
1.3 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.2 |
1.6 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 |
0.9 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.2 |
1.5 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 |
0.2 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.2 |
1.1 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.2 |
0.6 |
GO:0033084 |
regulation of immature T cell proliferation in thymus(GO:0033084) |
| 0.2 |
1.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 |
0.6 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.2 |
0.8 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
0.4 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.2 |
0.6 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.2 |
3.2 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.2 |
1.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
1.0 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.2 |
0.6 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.2 |
0.6 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 |
0.6 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
1.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 |
0.6 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.2 |
0.6 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.2 |
1.6 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
0.6 |
GO:0034370 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
| 0.2 |
0.4 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 |
0.8 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
0.2 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.2 |
0.4 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.2 |
0.6 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
1.2 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.2 |
1.0 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.2 |
0.4 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 |
0.6 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 |
0.6 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.2 |
1.0 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
0.4 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.2 |
1.5 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.2 |
1.9 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
0.6 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.2 |
0.9 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.2 |
0.4 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.8 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.2 |
0.4 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
0.4 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.2 |
0.2 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
1.7 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
0.2 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 |
1.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 |
2.8 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.2 |
0.6 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.2 |
1.8 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.2 |
1.6 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.2 |
0.2 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.2 |
0.7 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.2 |
0.4 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.2 |
0.5 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.2 |
0.4 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 |
2.1 |
GO:0021924 |
cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.2 |
0.4 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.2 |
0.2 |
GO:0045073 |
chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) positive regulation of chemokine biosynthetic process(GO:0045080) chemokine metabolic process(GO:0050755) |
| 0.2 |
1.1 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.2 |
0.5 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.2 |
1.8 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.2 |
2.8 |
GO:0031100 |
organ regeneration(GO:0031100) |
| 0.2 |
0.5 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.2 |
0.5 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.2 |
1.0 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
1.7 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.2 |
0.3 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 |
0.2 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
1.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
0.2 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
0.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.2 |
0.7 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.2 |
1.0 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 |
1.4 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.2 |
0.8 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.2 |
0.7 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.2 |
0.3 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.2 |
0.2 |
GO:1905050 |
positive regulation of metallopeptidase activity(GO:1905050) |
| 0.2 |
1.7 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
0.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.2 |
0.5 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.2 |
1.0 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.2 |
0.7 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
2.6 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.2 |
0.3 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
0.3 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.2 |
0.5 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
0.2 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.2 |
0.5 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.5 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.2 |
0.5 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.2 |
0.6 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
0.6 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 |
0.6 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
0.2 |
GO:0034470 |
ncRNA processing(GO:0034470) |
| 0.2 |
0.3 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.2 |
0.6 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
1.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
1.1 |
GO:0060872 |
semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
| 0.2 |
0.2 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.2 |
1.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
0.3 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.5 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.2 |
0.6 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
0.3 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.2 |
0.5 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
0.5 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.2 |
0.5 |
GO:0048369 |
lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
| 0.2 |
0.2 |
GO:0007063 |
regulation of sister chromatid cohesion(GO:0007063) |
| 0.2 |
0.5 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.3 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.1 |
0.3 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.1 |
0.4 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.4 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.1 |
1.5 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.9 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.3 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 0.1 |
0.6 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.4 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 |
0.7 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.1 |
0.3 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 |
0.6 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 |
0.7 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
1.4 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.1 |
1.4 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.7 |
GO:0033692 |
cellular polysaccharide biosynthetic process(GO:0033692) |
| 0.1 |
0.4 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.4 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.1 |
1.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.1 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
1.0 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.7 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
1.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.7 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.3 |
GO:0014841 |
skeletal muscle satellite cell proliferation(GO:0014841) |
| 0.1 |
1.0 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.6 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 |
0.4 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.3 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.1 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.1 |
1.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
1.0 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.1 |
0.5 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.7 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.1 |
0.1 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 |
0.8 |
GO:0030540 |
female genitalia development(GO:0030540) |
| 0.1 |
0.8 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 |
0.1 |
GO:0071910 |
determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
0.3 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
0.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.1 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) genitalia morphogenesis(GO:0035112) |
| 0.1 |
0.4 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.1 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.1 |
1.2 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.1 |
0.3 |
GO:0035855 |
megakaryocyte differentiation(GO:0030219) megakaryocyte development(GO:0035855) |
| 0.1 |
0.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.5 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.1 |
1.2 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.9 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.3 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.1 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 |
0.6 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.5 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.4 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 |
0.6 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.5 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.1 |
1.3 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 |
0.3 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.1 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.1 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.6 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.4 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
0.4 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
0.5 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.2 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.1 |
0.9 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.9 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
0.7 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
2.0 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
1.7 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.4 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
1.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.1 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
0.2 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
0.2 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
0.1 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.1 |
0.1 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.1 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.1 |
0.4 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 |
0.2 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.1 |
0.6 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.4 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 0.1 |
0.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
1.5 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.1 |
0.2 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.1 |
0.2 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.1 |
1.1 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.5 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.5 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.3 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.9 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
0.3 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.1 |
0.6 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.1 |
0.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.2 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.1 |
GO:0021513 |
spinal cord dorsal/ventral patterning(GO:0021513) |
| 0.1 |
0.1 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
| 0.1 |
0.4 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
1.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.3 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.1 |
0.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
0.8 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.1 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 0.1 |
1.7 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.5 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.5 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.5 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.3 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.3 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.9 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.4 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.4 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.1 |
0.9 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.5 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.9 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
0.5 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.7 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.1 |
1.3 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.5 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.4 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.1 |
0.3 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.1 |
0.5 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
1.1 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
0.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
0.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.4 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 0.1 |
0.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.1 |
0.3 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.7 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.3 |
GO:0071281 |
cellular response to iron ion(GO:0071281) |
| 0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.4 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.7 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 |
0.3 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
1.0 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.4 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.6 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.9 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.2 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.1 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 |
2.9 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.3 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 |
0.6 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.2 |
GO:0022403 |
cell cycle phase(GO:0022403) |
| 0.1 |
0.5 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
0.3 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
1.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.3 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
0.7 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.5 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.1 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
2.7 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.3 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 |
0.4 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 |
0.6 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.9 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 |
0.4 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.1 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.2 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.3 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.2 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.1 |
0.5 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.3 |
GO:1903273 |
regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.1 |
0.7 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.6 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.1 |
0.4 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
0.1 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.1 |
0.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
1.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.4 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.1 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.1 |
0.3 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.1 |
0.1 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 0.1 |
1.2 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.1 |
0.2 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.6 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.5 |
GO:0045124 |
regulation of bone resorption(GO:0045124) |
| 0.1 |
2.1 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.4 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
0.4 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.1 |
0.4 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
0.4 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.1 |
1.2 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
1.0 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
0.4 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
2.9 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
0.3 |
GO:0032962 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 |
0.3 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.1 |
0.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.4 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.1 |
0.3 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.3 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.1 |
0.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.1 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.1 |
0.9 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.6 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.1 |
0.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.3 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
0.3 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.7 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.2 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 |
0.6 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.1 |
3.3 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.3 |
GO:0071236 |
cellular response to antibiotic(GO:0071236) |
| 0.1 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.2 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
0.6 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 |
0.5 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.1 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 |
0.4 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.1 |
0.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.1 |
0.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.2 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.3 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
0.9 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
2.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.2 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 |
0.2 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.8 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.1 |
0.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
2.6 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
0.4 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.7 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.1 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.8 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.1 |
1.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.2 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.1 |
0.4 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
1.1 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 |
0.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.3 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 |
0.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
2.3 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
1.0 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 |
0.2 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.1 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
0.2 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.7 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
0.8 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.1 |
GO:0010833 |
telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 |
0.2 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.1 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.3 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.7 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.5 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.1 |
0.6 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.4 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 |
0.1 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.1 |
0.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.3 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 |
0.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
0.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.4 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.1 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.1 |
1.1 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.8 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.4 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.3 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.3 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
0.1 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 |
0.1 |
GO:0003097 |
renal water transport(GO:0003097) |
| 0.1 |
0.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.3 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
0.1 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.1 |
0.2 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.1 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
1.0 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.5 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.1 |
0.1 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) |
| 0.1 |
0.1 |
GO:0042511 |
positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.1 |
0.5 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.1 |
0.1 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 |
0.1 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.1 |
0.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
1.1 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
0.2 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.1 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.3 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
0.1 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.1 |
0.4 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.1 |
0.1 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
1.1 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
0.3 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
0.5 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
2.3 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.7 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) |
| 0.1 |
1.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.6 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.1 |
0.4 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.1 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
0.3 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.1 |
1.1 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 |
1.7 |
GO:1902668 |
negative regulation of axon guidance(GO:1902668) |
| 0.1 |
0.5 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.1 |
0.2 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.1 |
0.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
1.0 |
GO:0034205 |
beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) |
| 0.1 |
0.1 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
0.1 |
GO:0008050 |
courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 |
0.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.2 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.3 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 0.1 |
0.6 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.1 |
GO:2000650 |
negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.1 |
0.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.1 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.1 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.2 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 |
0.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.3 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.1 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.1 |
0.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.3 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) |
| 0.1 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.1 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.5 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.1 |
1.3 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 0.1 |
0.2 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
1.1 |
GO:1904407 |
positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
| 0.1 |
0.8 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.1 |
0.6 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.3 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) regulation of protein homooligomerization(GO:0032462) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.3 |
GO:0060502 |
epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
| 0.1 |
0.9 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.1 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.4 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.1 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.1 |
0.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.2 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
0.5 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.1 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
0.3 |
GO:0019755 |
one-carbon compound transport(GO:0019755) |
| 0.1 |
0.2 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
0.2 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.4 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.1 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.1 |
0.1 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
0.4 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.2 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 |
0.3 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
0.4 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 |
0.4 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.2 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.1 |
0.2 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
0.2 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.1 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.2 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.0 |
0.0 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.3 |
GO:0046456 |
icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
| 0.0 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.6 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.4 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.1 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.0 |
1.5 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.0 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.0 |
0.0 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.0 |
0.2 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.0 |
0.2 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.0 |
0.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.0 |
0.7 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.2 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.0 |
0.0 |
GO:0002369 |
T cell cytokine production(GO:0002369) |
| 0.0 |
0.4 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.0 |
0.1 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.0 |
0.6 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.3 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.4 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.5 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.2 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.0 |
0.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.3 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.3 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.0 |
0.3 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.3 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 |
0.1 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.0 |
0.5 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.5 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.3 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.0 |
0.0 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.2 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.4 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.0 |
0.1 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.0 |
0.1 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.0 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.0 |
0.2 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.0 |
0.1 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.0 |
0.0 |
GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 |
0.0 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.0 |
0.6 |
GO:0061045 |
negative regulation of wound healing(GO:0061045) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.2 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.0 |
0.7 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
1.9 |
GO:0016525 |
negative regulation of angiogenesis(GO:0016525) |
| 0.0 |
0.2 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.3 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.1 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 |
0.6 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.2 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.1 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.0 |
0.1 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) post-embryonic eye morphogenesis(GO:0048050) |
| 0.0 |
0.4 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.0 |
0.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.1 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
0.1 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.0 |
0.3 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.0 |
1.2 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 |
0.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.0 |
0.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.1 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.2 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 |
0.2 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.3 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.0 |
0.6 |
GO:0072376 |
protein activation cascade(GO:0072376) |
| 0.0 |
0.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.2 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.0 |
0.2 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.0 |
0.4 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.0 |
0.6 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.0 |
0.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.6 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.5 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.2 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.3 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.2 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
| 0.0 |
0.5 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.6 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.0 |
0.0 |
GO:1903798 |
regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
| 0.0 |
0.0 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.4 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.5 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.0 |
0.1 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
0.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.4 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.3 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 |
0.3 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 |
0.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.1 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
1.8 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.1 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.0 |
0.2 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.1 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
0.1 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.1 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.0 |
0.9 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.0 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.3 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.0 |
0.7 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.1 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.0 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.0 |
0.1 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.4 |
GO:0071466 |
cellular response to xenobiotic stimulus(GO:0071466) |
| 0.0 |
0.0 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.2 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.0 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.2 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.0 |
0.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.0 |
GO:0072677 |
eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.0 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.4 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.2 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.2 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.0 |
0.4 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.1 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.0 |
0.0 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.3 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.0 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.0 |
0.2 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.0 |
0.2 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.0 |
0.9 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.1 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.3 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.0 |
0.0 |
GO:0072576 |
liver morphogenesis(GO:0072576) |
| 0.0 |
0.3 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.1 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.0 |
0.1 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.0 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.2 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.3 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.1 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.0 |
GO:0045978 |
negative regulation of glycolytic process(GO:0045820) negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.9 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.1 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.0 |
GO:1900221 |
regulation of beta-amyloid clearance(GO:1900221) |
| 0.0 |
0.1 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.0 |
0.3 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.0 |
0.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.1 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.6 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.2 |
GO:0032612 |
interleukin-1 production(GO:0032612) |
| 0.0 |
0.0 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.0 |
0.3 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.6 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.1 |
GO:0042987 |
amyloid precursor protein catabolic process(GO:0042987) |
| 0.0 |
0.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.0 |
GO:0000052 |
citrulline metabolic process(GO:0000052) citrulline biosynthetic process(GO:0019240) |
| 0.0 |
0.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.1 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.0 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.0 |
0.1 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.0 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 |
0.2 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.1 |
GO:0036093 |
germ cell proliferation(GO:0036093) |
| 0.0 |
0.0 |
GO:0098754 |
detoxification(GO:0098754) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.1 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.1 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.0 |
0.0 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.0 |
0.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.9 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.0 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.0 |
0.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.0 |
0.3 |
GO:0042307 |
positive regulation of protein import into nucleus(GO:0042307) |
| 0.0 |
0.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.3 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.1 |
GO:0070231 |
T cell apoptotic process(GO:0070231) |
| 0.0 |
0.2 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.0 |
0.2 |
GO:0036119 |
response to platelet-derived growth factor(GO:0036119) |
| 0.0 |
0.2 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.8 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.1 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.0 |
0.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.0 |
GO:1901838 |
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 |
0.0 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.1 |
GO:0060283 |
negative regulation of oocyte development(GO:0060283) |
| 0.0 |
0.1 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.0 |
0.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.0 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.1 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.2 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.1 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.0 |
0.0 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.1 |
GO:0045624 |
positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.0 |
0.2 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.0 |
0.1 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.0 |
0.1 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.0 |
GO:0045713 |
low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.0 |
0.1 |
GO:0042308 |
negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.0 |
0.1 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.0 |
0.0 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.3 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.0 |
0.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.1 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.0 |
0.2 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.0 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.0 |
0.0 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.0 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.0 |
0.1 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.0 |
0.3 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.0 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.1 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.9 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.0 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.1 |
GO:1904591 |
positive regulation of protein import(GO:1904591) |
| 0.0 |
0.2 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.5 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.0 |
0.1 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.1 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 |
0.0 |
GO:0042482 |
positive regulation of odontogenesis(GO:0042482) |
| 0.0 |
0.0 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.2 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.1 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.1 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.0 |
0.1 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.0 |
0.1 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.0 |
GO:0042345 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.0 |
0.0 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.0 |
0.3 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.0 |
0.1 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.0 |
0.1 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.0 |
0.1 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.0 |
0.1 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.0 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.0 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.0 |
0.1 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.0 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.0 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.1 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 |
0.1 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.0 |
GO:0071674 |
mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.0 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.0 |
0.1 |
GO:0051905 |
pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
| 0.0 |
0.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.0 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.0 |
0.0 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 |
0.1 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.0 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 |
0.2 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.0 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.0 |
0.1 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.0 |
0.0 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.0 |
0.2 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.0 |
0.1 |
GO:0045580 |
regulation of T cell differentiation(GO:0045580) |
| 0.0 |
0.0 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.0 |
0.0 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.0 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 0.0 |
0.0 |
GO:0060602 |
branch elongation of an epithelium(GO:0060602) |
| 0.0 |
0.0 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.0 |
0.0 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.0 |
GO:0034440 |
lipid oxidation(GO:0034440) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.0 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.1 |
GO:0000737 |
DNA catabolic process, endonucleolytic(GO:0000737) |
| 0.0 |
0.0 |
GO:0044854 |
plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.0 |
0.0 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.2 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.0 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.1 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 |
0.1 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 |
0.2 |
GO:0015758 |
glucose transport(GO:0015758) |
| 0.0 |
0.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.0 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.0 |
0.0 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.0 |
0.1 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.0 |
1.1 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.1 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.0 |
0.1 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.0 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.0 |
0.0 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.0 |
0.7 |
GO:0010466 |
negative regulation of peptidase activity(GO:0010466) |
| 0.0 |
0.0 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.0 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.0 |
0.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.1 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.0 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
